Murillo-García Nancy, Papiol Sergi, Fernández-Cacho Luis Manuel, Fatjó-Vilas Mar, Ayesa-Arriola Rosa
Research Group on Mental Illnesses, Valdecilla Biomedical Research (IDIVAL), Santander, Spain.
Department of Molecular Biology, School of Medicine, University of Cantabria, Santander, Spain.
Eur Psychiatry. 2024 Mar 11;67(1):e31. doi: 10.1192/j.eurpsy.2024.24.
The intelligence quotient (IQ) of patients with first-episode psychosis (FEP) and their unaffected relatives may be related to the genetic burden of schizophrenia (SCZ). The polygenic score approach can be useful for testing this question.
To assess the contribution of the polygenic risk scores for SCZ (PGS-SCZ) and polygenic scores for IQ (PGS-IQ) to the individual IQ and its difference from the mean IQ of the family (named family-IQ) through a family-based design in an FEP sample.
The PAFIP-FAMILIES sample (Spain) consists of 122 FEP patients, 131 parents, 94 siblings, and 176 controls. They all completed the WAIS Vocabulary subtest for IQ estimation and provided a DNA sample. We calculated PGS-SCZ and PGS-IQ using the continuous shrinkage method. To account for relatedness in our sample, we performed linear mixed models. We controlled for covariates potentially related to IQ, including age, years of education, sex, and ancestry principal components.
FEP patients significantly deviated from their family-IQ. FEP patients had higher PGS-SCZ than other groups, whereas the relatives had intermediate scores between patients and controls. PGS-IQ did not differ between groups. PGS-SCZ significantly predicted the deviation from family-IQ, whereas PGS-IQ significantly predicted individual IQ.
PGS-SCZ discriminated between different levels of genetic risk for the disorder and was specifically related to patients' lower IQ in relation to family-IQ. The genetic background of the disorder may affect neurocognition through complex pathological processes interacting with environmental factors that prevent the individual from reaching their familial cognitive potential.
首发精神病(FEP)患者及其未患病亲属的智商(IQ)可能与精神分裂症(SCZ)的遗传负担有关。多基因评分方法有助于检验这一问题。
通过基于家系的设计,在一个FEP样本中评估SCZ的多基因风险评分(PGS-SCZ)和IQ的多基因评分(PGS-IQ)对个体IQ及其与家族平均IQ差异(称为家族IQ)的贡献。
PAFIP-FAMILIES样本(西班牙)包括122名FEP患者、131名父母、94名兄弟姐妹和176名对照。他们都完成了用于IQ评估的韦氏成人智力量表词汇分测验,并提供了DNA样本。我们使用连续收缩法计算PGS-SCZ和PGS-IQ。为了考虑样本中的相关性,我们进行了线性混合模型分析。我们控制了可能与IQ相关的协变量,包括年龄、受教育年限、性别和祖先主成分。
FEP患者与其家族IQ存在显著差异。FEP患者的PGS-SCZ高于其他组,而亲属的得分介于患者和对照之间。各组之间的PGS-IQ没有差异。PGS-SCZ显著预测了与家族IQ的差异,而PGS-IQ显著预测了个体IQ。
PGS-SCZ区分了该疾病不同水平的遗传风险,并且与患者相对于家族IQ较低的IQ具体相关。该疾病的遗传背景可能通过与环境因素相互作用的复杂病理过程影响神经认知,这些环境因素阻碍个体发挥其家族认知潜力。